Form 4: Varex Imaging Director Sells Over 2,500 Shares Under Pre-Arranged Trading Plan

Varex Imaging Corp. Director Jay K. Kunkel sold 2,575 shares of common stock for $7.77 per share on June 18, 2025, under a Rule 10b5-1 trading plan.

Summary

• Jay K. Kunkel, a Director of Varex Imaging Corp. (VREX), reported the sale of 2,575 shares of common stock.
• The transaction occurred on June 18, 2025.
• Each share was sold at a price of $7.77.
• The sale was conducted as a direct ownership transaction.
• Following this transaction, Mr. Kunkel beneficially owns 22,477 shares of Varex Imaging Corp. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the fact that it was conducted under a Rule 10b5-1 plan suggests it was pre-scheduled and not necessarily indicative of new negative information, thus mitigating potential negative sentiment.

Positives

• The sale was executed under a Rule 10b5-1(c) plan, indicating it was a pre-scheduled transaction and not necessarily based on new, negative material non-public information.

Negatives

• A director reducing their direct ownership stake, even if pre-planned, can sometimes be perceived by the market as a reduction in alignment with shareholder interests or a lack of confidence, although the 10b5-1 plan mitigates this perception.

Risks

• No specific risks related to company operations or financial health are disclosed in this Form 4 filing, as it primarily reports an insider transaction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information related to broader industry trends or competitive landscape.

Related Party Transactions

• Director Jay K. Kunkel, a related party, sold 2,575 shares of Varex Imaging Corp. common stock at $7.77 per share on June 18, 2025.

Stakeholder Impact

• Shareholders may observe a director reducing their stake, which could lead to questions about management's long-term commitment or confidence, although the 10b5-1 plan provides context for the transaction.

Key Dates

Keywords

Varex Imaging Corp, VREX, SEC Form 4, Insider Trading, Stock Sale, Director, Jay K. Kunkel, Rule 10b5-1 Plan, Beneficial Ownership